Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Adobe
ADBE
$109B
| $2.14M | 0.08% |
29,544
+24,253
| +458% | +$1.56M |
|
|
MON
102
DELISTED
Monsanto Co
MON
| $2.12M | 0.08% |
16,983
-8,221
| -33% | -$962K |
|
103
FedEx
FDX
$76.9B
| $2.08M | 0.08% |
13,776
+9,796
| +246% | +$1.37M |
|
104
Nike
NKE
$60.5B
| $2.08M | 0.08% |
53,662
+20,722
| +63% | +$771K |
|
|
AXAS
105
DELISTED
Abraxas Petroleum Corp
AXAS
| $2.07M | 0.08% |
16,569
+13,627
| +463% | +$1.39M |
|
106
Acadia Healthcare
ACHC
$2.59B
| $2.06M | 0.08% |
+45,300
| New | +$1.99M |
|
|
PARA
107
DELISTED
Paramount Global Class B
PARA
| $2.02M | 0.08% |
32,457
+20,155
| +164% | +$1.2M |
|
108
AstraZeneca
AZN
$257B
| $2.01M | 0.08% |
+27,100
| New | +$1.96M |
|
109
Huntington Ingalls Industries
HII
$11.8B
| $1.95M | 0.07% |
20,607
+2,884
| +16% | +$288K |
|
|
RALY
110
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $1.9M | 0.07% |
174,629
+11,770
| +7% | +$147K |
|
|
ENH
111
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $1.86M | 0.07% |
36,074
+26,674
| +284% | +$1.39M |
|
112
IBM
IBM
$222B
| $1.85M | 0.07% |
+10,650
| New | +$1.92M |
|
|
AL
113
DELISTED
Air Lease Corp
AL
| $1.8M | 0.07% |
46,717
+9,094
| +24% | +$348K |
|
|
DST
114
DELISTED
DST Systems Inc.
DST
| $1.8M | 0.07% |
39,098
+21,438
| +121% | +$986K |
|
|
KND
115
DELISTED
Kindred Healthcare
KND
| $1.8M | 0.07% |
+77,983
| New | +$1.91M |
|
|
MNDT
116
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.75M | 0.07% |
43,250
-208,588
| -83% | -$8.13M |
|
|
MRD
117
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
| $1.75M | 0.07% |
+71,913
| New | +$1.73M |
|
118
eBay
EBAY
$46.3B
| $1.73M | 0.07% |
82,129
-633,986
| -89% | -$13.8M |
|
|
CIT
119
DELISTED
CIT Group Inc.
CIT
| $1.69M | 0.06% |
37,017
+8,079
| +28% | +$364K |
|
|
BHI
120
DELISTED
Baker Hughes
BHI
| $1.69M | 0.06% |
22,726
+10,601
| +87% | +$738K |
|
121
Bristol-Myers Squibb
BMY
$137B
| $1.68M | 0.06% |
34,712
+18,363
| +112% | +$905K |
|
122
Bunge Global
BG
$21.7B
| $1.68M | 0.06% |
22,146
+2,271
| +11% | +$176K |
|
123
General Mills
GIS
$21.4B
| $1.68M | 0.06% |
31,878
+12,594
| +65% | +$672K |
|
|
LO
124
DELISTED
LORILLARD INC COM STK
LO
| $1.67M | 0.06% |
+27,332
| New | +$1.59M |
|
125
CALL
lululemon athletica
LULU
$13.7B
| $1.62M | 0.06% |
+40,000
| New | +$1.82M |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.